Companies AMN Healthcare Services
AMN Healthcare Services (AMN): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me AMN Healthcare Services’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers53rd pct.Of 16 peer CEOs
CEO pay, last three years
- $6,660,480FY2023
- $9,562,742FY2024
- $10,669,780FY2025
CEO total pay was $10,669,780 in fiscal 2025, up from $9,562,742 in fiscal 2024.
FY2025: salary $1,060,000 · bonus $0 · stock awards $8,363,117 · option awards $0
Executives and directors
Cary Grace · CEOBrian Scott · CFOMark Hagan · ExecutiveWhitney Laughlin · General CounselCelia P. Huber · Independent DirectorDaphne E. Jones · Independent DirectorDouglas D. Wheat · Former director (through FY2025)James H. Hinton · Independent DirectorJorge A. Caballero · Independent DirectorMark G. Foletta · Chair of the BoardR. Jeffrey Harris · Independent DirectorSylvia Trent-Adams · Independent DirectorTeri G. Fontenot · Independent Director
Frequently asked questions
Who was the highest-paid executive at AMN Healthcare Services in fiscal 2025?
As disclosed, Cary Grace (PEO, President & CEO) was the highest-paid executive at AMN Healthcare Services in fiscal 2025, with total compensation of $10,669,780.
How does AMN Healthcare Services's chief executive pay compare to its disclosed peer group?
As disclosed, Cary Grace's total compensation ranked at the 53rd percentile of AMN Healthcare Services's disclosed peer group.
What is AMN Healthcare Services's CEO-to-median employee pay ratio?
As disclosed, AMN Healthcare Services's CEO-to-median employee pay ratio was 123:1.
How did shareholders vote on AMN Healthcare Services's executive compensation?
As disclosed, 76.27% of shareholders supported AMN Healthcare Services's executive compensation in the latest say-on-pay vote.
How much does AMN Healthcare Services spend in total on board compensation for fiscal 2025?
As disclosed, AMN Healthcare Services reported total board compensation of $2,526,985 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Cary Grace | $1,060,000 | $0 | $8,363,117 | $0 | $1,146,125 | $0 | $100,538 | $10,669,780 |
| PEO, President & CEO | ||||||||
| Brian Scott | 630,000 | 0 | 2,125,602 | 0 | 563,850 | 0 | 57,623 | 3,377,075 |
| PFO, CFO & COO | ||||||||
| Mark Hagan | 550,000 | 0 | 1,594,204 | 0 | 443,025 | 0 | 54,854 | 2,642,083 |
| Chief Information & Digital Officer | ||||||||
| Whitney Laughlin | 500,000 | 0 | 850,209 | 0 | 323,750 | 0 | 40,784 | 1,704,243 |
| Chief Legal Officer & Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Cary Grace | $10,669,780 | $9,562,742 | $6,660,480 | ↑ +1,107,038 |
| Brian Scott | 3,377,075 | 2,253,554 | — | ↑ +1,123,521 |
| Mark Hagan | 2,642,083 | 4,195,993 | 2,303,132 | ↓ −1,553,910 |
| Whitney Laughlin | 1,704,243 | 2,080,732 | 814,465 | ↓ −376,489 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation philosophy is that compensation realized by executives should (i) align with shareholders interests, (ii) reflect the individual skills and contributions of the executive in achieving the strategic, financial, and operational goals of the Company and (iii) reflect the leadership they demonstrate in promoting our values-based culture and commitment to corporate social responsibility.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Whitney Laughlin | PSU | 2025-01-15 | 2,297 | 9,188 | — | 16,079 | $290,249 |
| Brian Scott | PSU | 2025-01-15 | 5,743 | 22,970 | — | 40,198 | 725,622 |
| Mark Hagan | PSU | 2025-01-15 | 4,307 | 17,228 | — | 30,149 | 544,233 |
| Cary Grace | PSU | 2025-01-15 | 16,510 | 66,041 | — | 115,571 | 2,086,235 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Whitney Laughlin | $0 | $290,249 | $0 | 100.0% |
| Brian Scott | 0 | 725,622 | 0 | 100.0% |
| Mark Hagan | 0 | 544,233 | 0 | 100.0% |
| Cary Grace | 0 | 2,086,235 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Whitney Laughlin | RSU | 203 | — | $2,018 |
| Whitney Laughlin | RSU | 486 | — | 7,659 |
| Whitney Laughlin | RSU | 498 | — | 4,975 |
| Whitney Laughlin | RSU | 567 | — | 8,936 |
| Whitney Laughlin | RSU | 995 | — | 15,681 |
| Mark Hagan | RSU | 1,433 | — | 14,316 |
| Mark Hagan | RSU | 1,459 | — | 22,994 |
| Whitney Laughlin | RSU | 1,521 | — | 15,195 |
| Mark Hagan | RSU | 1,703 | — | 26,839 |
| Mark Hagan | RSU | 1,866 | — | 29,408 |
| Whitney Laughlin | RSU | 2,297 | — | 36,201 |
| Brian Scott | RSU | 3,700 | — | 58,312 |
| Mark Hagan | RSU | 4,307 | — | 67,878 |
| Mark Hagan | RSU | 4,565 | — | 45,604 |
| Whitney Laughlin | RSU | 4,976 | — | 49,710 |
| Brian Scott | RSU | 5,742 | — | 90,494 |
| Cary Grace | RSU | 6,924 | — | 109,122 |
| Cary Grace | RSU | 7,656 | — | 120,659 |
| Cary Grace | RSU | 8,078 | — | 127,309 |
| Mark Hagan | RSU | 9,331 | — | 93,217 |
| Cary Grace | RSU | 9,935 | — | 237,645 |
| Whitney Laughlin | RSU | 10,719 | — | 168,931 |
| Cary Grace | RSU | 16,510 | — | 260,198 |
| Mark Hagan | RSU | 20,099 | — | 316,760 |
| Cary Grace | RSU | 21,652 | — | 216,403 |
| Brian Scott | RSU | 24,797 | — | 247,722 |
| Brian Scott | RSU | 26,799 | — | 422,352 |
| Cary Grace | RSU | 77,048 | — | 1,214,276 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Mark G. FolettaIndependent · Board Chair | $198,877 | $169,997 | $0 | $0 | $0 | $368,874 |
| Douglas D. WheatIndependent · Departed during FY | 310,000 | 0 | 0 | 0 | 0 | 310,000 |
| Teri G. FontenotIndependent · Audit (Chair) | 120,000 | 169,997 | 0 | 0 | 0 | 289,997 |
| Jorge A. CaballeroIndependent · Corporate Governance and Compliance (Chair) · Audit | 105,000 | 169,997 | 0 | 0 | 0 | 274,997 |
| Sylvia Trent-AdamsIndependent · Corporate Governance and Compliance · Compensation (Chair) | 103,297 | 169,997 | 0 | 0 | 0 | 273,294 |
| R. Jeffrey HarrisIndependent · Corporate Governance and Compliance · Compensation | 90,000 | 169,997 | 0 | 0 | 0 | 259,997 |
| Daphne E. JonesIndependent · Corporate Governance and Compliance · Audit | 90,000 | 169,997 | 0 | 0 | 0 | 259,997 |
| James H. HintonIndependent · Audit · Compensation | 90,000 | 169,997 | 0 | 0 | 0 | 259,997 |
| Celia P. HuberIndependent · Corporate Governance and Compliance · Compensation | 59,835 | 169,997 | 0 | 0 | 0 | 229,832 |
| Cary GraceEmployee director | 0 | 0 | 0 | 0 | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $90,000 |
|---|---|
| Annual equity retainer | $170,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 15,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,167,009 |
| Equity awards (grant-date value) | $1,359,976 |
| All other compensation | $0 |
| Total cost of the board | $2,526,985 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names AMN Healthcare Services as a peer
Companies that benchmark against AMN
16 companies name AMN as a compensation peer
- Acadia Healthcare Company, Inc.ACHCFY2025
- AdaptHealth Corp.AHCOFY2025
- Aveanna Healthcare Holdings, Inc.AVAHFY2025
- CBIZ, Inc.CBZFY2025
- CHEMED CORPCHEFY2025
- CRAWFORD & COCRD-AFY2025
- CROSS COUNTRY HEALTHCARE INCCCRNFY2025
- Encompass Health CorpEHCFY2025
- Evolent Health, Inc.EVHFY2025
- HEALTHCARE SERVICES GROUP INCHCSGFY2025
- MAXIMUS, INC.MMSFY2025
- Option Care Health, Inc.OPCHFY2025
- PATTERSON COMPANIES, INC.PDCOFY2024
- Premier, Inc.PINCFY2024
- Surgery Partners, Inc.SGRYFY2025
- Teladoc Health, Inc.TDOCFY2025
Each company listed discloses AMN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AMN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
PINC Premier, Inc.RCM R1 RCM, Inc.AMED Amedisys, Inc.MD Pediatrix Medical Group, Inc.EFOR ASGN IncorporatedKFY Korn FerryNSP Insperity, Inc.ALIT Alight, Inc.CCRN Cross Country Healthcare, Inc.EVH Evolent Health, Inc.RHI Robert Half International Inc.EHC Encompass HealthOPCH Option Care HealthTNET TriNet Group, Inc.KELYA Kelly ServicesTDOC Teledoc Health
Peer reciprocity
Of the companies AMN Healthcare Services names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
✓ Premier, Inc. (PINC)84— R1 RCM, Inc. (RCM)85 Amedisys, Inc. (AMED) Pediatrix Medical Group, Inc. (MD)— ASGN Incorporated (EFOR)86— Korn Ferry (KFY)87— Insperity, Inc. (NSP)88— Alight, Inc. (ALIT)89✓ Cross Country Healthcare, Inc. (CCRN)90✓ Evolent Health, Inc. (EVH)91— Robert Half International Inc. (RHI)92✓ Encompass Health (EHC)93✓ Option Care Health (OPCH)94— TriNet Group, Inc. (TNET)95— Kelly Services (KELYA)96✓ Teledoc Health (TDOC)97
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including AMN Healthcare Services.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Insperity, Inc. | 2025 | Paul Sarvadi | $1,206,000 | $14,558,893 | $0 | $1,019,684 | $16,813,013 |
| 2 | Korn Ferry | 2026 | Gary Burnison | 1,000,000 | 11,982,027 | 0 | 3,000,000 | 16,117,290 |
| 3 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 4 | R1 RCM, Inc. | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 5 | Pediatrix Medical Group, Inc. | 2025 | Mark Ordan | 970,014 | 8,456,024 | 0 | 2,700,000 | 14,140,217 |
| 6 | Premier, Inc. | 2024 | Michael Alkire | 1,095,876 | 8,500,039 | 0 | 1,800,150 | 11,806,381 |
| 7 | Teledoc Health | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 8 | AMN Healthcare Services | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 9 | Alight, Inc. | 2025 | David Guilmette | 870,000 | 9,588,062 | 0 | 0 | 10,645,531 |
| 10 | TriNet Group, Inc. | 2025 | Michael Simonds | 1,000,000 | 8,250,004 | 0 | 1,272,000 | 10,552,055 |
| 11 | Asgn Incorporated | 2025 | Theodore Hanson | 1,100,000 | 7,787,118 | 0 | 1,566,066 | 10,475,672 |
| 12 | Encompass Health | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 13 | Option Care Health | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 14 | Robert Half International Inc. | 2025 | M. Keith Waddell | 500,000 | 4,532,948 | 0 | 839,330 | 6,073,178 |
| 15 | Kelly Services | 2025 | Christopher Layden | 307,692 | 4,000,003 | 0 | 450,000 | 5,207,696 |
| 16 | Cross Country Healthcare, Inc. | 2025 | Kevin Clark | 18,269 | 2,177,134 | 0 | 0 | 2,355,403 |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| AMN Healthcare Services | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Alight, Inc. | not disclosed | PSU 50 · RSU 50 | Yes — Relative Total Shareholder Return (TSR) | Mercer (US) Inc. |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Asgn Incorporated | not disclosed | RSU 50 · PSU 50 | Yes — Relative TSR | Semler Brossy Consulting Group, LLC |
| Cross Country Healthcare, Inc. | 20% | RSU 60 · PSU 40 | No | Pearl Meyer |
| Encompass Health | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| Insperity, Inc. | not disclosed | PSU 65 · RSU 35 | not disclosed | FW Cook |
| Kelly Services | not disclosed | Performance Shares 75 · Restricted Stock 25 | not disclosed | Pearl Meyer |
| Korn Ferry | not disclosed | PRSU 50 · RSU 50 | not disclosed | Pearl Meyer |
| Option Care Health | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Pediatrix Medical Group, Inc. | 180% | RSU 50 · PSU 50 | No | Semler Brossy Consulting Group |
| Premier, Inc. | 109.1% | PSU 60 · RSU 40 | No | Mercer |
| R1 RCM, Inc. | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| Robert Half International Inc. | 59.1% | PRSU 100 | No | Frederic W. Cook & Co., Inc. |
| Teledoc Health | 73% | RSU 50 · PSU 50 | No | Aon |
| TriNet Group, Inc. | 84.8% | PSU 50 · RSU 50 | No | Meridian |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-01 | 22,728,186 | 7,071,111 | 40,119 | 76.27% | Passed |
| 2025 | 2025-05-02 | 23,059,546 | 6,703,892 | 52,763 | 77.48% | Passed |
| 2024 | 2024-04-19 | 31,193,222 | 2,035,138 | 48,384 | 93.88% | Passed |
| 2023 | 2023-05-17 | 31,076,423 | 2,612,615 | 228,644 | 92.24% | Passed |
| 2022 | 2022-05-06 | 34,433,004 | 3,700,735 | 345,359 | 90.3% | Passed |
| 2021 | 2021-04-21 | 38,941,383 | 2,872,881 | 443,041 | 93.13% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-01 | 76.27%a |
| 2025 | 2025-05-02 | 77.48%b |
| 2024 | 2024-04-19 | 93.88%c |
a. Approved under the standard stated in the filing — “Abstentions will not affect the outcome of the vote on Proposal 1.”.
b. Approved under the standard stated in the filing — “Abstentions will not affect the outcome of the vote on Proposal 1.”.
c. Approved under the standard stated in the filing — “Abstentions will not affect the outcome of the vote on Proposal 1.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 123 : 1 |
|---|---|
| CEO total compensation | $10,669,780 |
| Median employee compensation | $85,722 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Celia P. Huber | Director | 2026-05-01 | A | 8,304 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 9,563 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 5,555 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 9,563 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 4,048 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Teri G. Fontenot | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 9,563 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 6,009 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 4,048 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 9,563 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 6,009 | 0 | 0 | Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 5,555 | 0 | 0 | Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| James H. Hinton | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Eric P. Palmer | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-06-15 | D | 2,000 | 31 | 62,138 | Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-06-15 | D | 1,681 | 31 | 52,224 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-09-15 | D | 122 | 34 | 4,171 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-09-15 | A | 498 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-09-15 | — | 498 | — | — | 1 insider, 1 accrual row | ||
| Mark Hagan | Chief Information and Digital | 2026-10-15 | D | 9,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark Hagan | Chief Information and Digital | 2026-10-15 | D | 3,348 | 38 | 126,086 | Common | Form 4 ↗ |
| Mark Hagan | Chief Information and Digital | 2026-10-15 | A | 9,331 | 0 | 0 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | D | 4,976 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | D | 1,212 | 38 | 45,644 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | A | 4,976 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 42 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Celia P. Huber | Director | 2026-05-01 | A | 8,304 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 9,563 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 5,555 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 9,563 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 4,048 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Teri G. Fontenot | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Sylvia Trent-Adams | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 9,563 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 6,009 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | D | 4,048 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 9,563 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 6,009 | 0 | 0 | Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | D | 8,325 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daphne E. Jones | Director | 2026-05-01 | A | 8,325 | 0 | 0 | Common | Form 4 ↗ |
| R. Jeffrey Harris | Director | 2026-05-01 | A | 5,555 | 0 | 0 | Common | Form 4 ↗ |
| Jorge A. Caballero | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| James H. Hinton | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Eric P. Palmer | Director | 2026-05-01 | A | 8,304 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-06-15 | D | 2,000 | 31 | 62,138 | Common | Form 4 ↗ |
| Mark G. Foletta | Director | 2026-06-15 | D | 1,681 | 31 | 52,224 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-09-15 | D | 122 | 34 | 4,171 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-09-15 | A | 498 | 0 | 0 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-09-15 | D | 498 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark Hagan | Chief Information and Digital | 2026-10-15 | D | 9,331 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mark Hagan | Chief Information and Digital | 2026-10-15 | D | 3,348 | 38 | 126,086 | Common | Form 4 ↗ |
| Mark Hagan | Chief Information and Digital | 2026-10-15 | A | 9,331 | 0 | 0 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | D | 4,976 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | D | 1,212 | 38 | 45,644 | Common | Form 4 ↗ |
| Whitney Laughlin | Chief Legal Officer | 2026-10-15 | A | 4,976 | 0 | 0 | Common | Form 4 ↗ |
Sources (97 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Cary Grace. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 75. As printed: 10,669,780. View filing ↗
- Section 01, Brian Scott. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 75. As printed: 3,377,075. View filing ↗
- Section 01, Mark Hagan. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 75. As printed: 2,642,083. View filing ↗
- Section 01, Whitney Laughlin. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 75. As printed: 1,704,243. View filing ↗
- Section 03, Whitney Laughlin PSU. DEF 14A, filed 2026-03-18. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Scott PSU. DEF 14A, filed 2026-03-18. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Hagan PSU. DEF 14A, filed 2026-03-18. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Cary Grace PSU. DEF 14A, filed 2026-03-18. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-18. Section “CEO Pay Ratio”. As printed: 123 : 1. View filing ↗
- Section 08, Mark G. Foletta. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 368,874. View filing ↗
- Section 08, Douglas D. Wheat. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 310,000. View filing ↗
- Section 08, Teri G. Fontenot. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 289,997. View filing ↗
- Section 08, Jorge A. Caballero. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 274,997. View filing ↗
- Section 08, Sylvia Trent-Adams. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 273,294. View filing ↗
- Section 08, R. Jeffrey Harris. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 259,997. View filing ↗
- Section 08, Daphne E. Jones. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 259,997. View filing ↗
- Section 08, James H. Hinton. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 259,997. View filing ↗
- Section 08, Celia P. Huber. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 229,832. View filing ↗
- Section 08, Cary Grace. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Celia P. Huber 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jorge A. Caballero 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark G. Foletta 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark G. Foletta 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sylvia Trent-Adams 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teri G. Fontenot 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-07-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jorge A. Caballero 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark G. Foletta 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sylvia Trent-Adams 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Sylvia Trent-Adams 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-07-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Daphne E. Jones 2026-05-01. Form 4, filed 2026-07-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Jeffrey Harris 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jorge A. Caballero 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James H. Hinton 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eric P. Palmer 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark G. Foletta 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark G. Foletta 2026-06-15. Form 4, filed 2026-06-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-09-15. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-09-15. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-09-15. Form 4, filed 2026-09-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Hagan 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Hagan 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Hagan 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Whitney Laughlin 2026-10-15. Form 4, filed 2026-10-15. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-04. Item 5.07 · say-on-pay result. As reported: 76.27% (votes for as printed: 22,728,186). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-05. Item 5.07 · say-on-pay result. As reported: 77.48% (votes for as printed: 23,059,546). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-04-22. Item 5.07 · say-on-pay result. As reported: 93.88% (votes for as printed: 31,193,222). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,167,009 + equity 1,359,976 + all other 0 = 2,526,985, summed across the director compensation table rows.
- Insperity, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-14. CEO total compensation as printed in Insperity, Inc.'s own proxy. As printed: 16,813,013. View filing ↗
- Korn Ferry, Section 10b CEO total. DEF 14A, filed 2026-08-07. CEO total compensation as printed in Korn Ferry's own proxy. As printed: 16,117,290. View filing ↗
- Evolent Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. View filing ↗
- R1 RCM, Inc., Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in R1 RCM, Inc.'s own proxy. As printed: 14,159,376. View filing ↗
- Pediatrix Medical Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 14,140,217. View filing ↗
- Premier, Inc., Section 10b CEO total. DEF 14A, filed 2024-10-21. CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. View filing ↗
- Teledoc Health, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teledoc Health's own proxy. As printed: 11,202,996. View filing ↗
- AMN Healthcare Services (subject), Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare Services's own proxy. As printed: 10,669,780. View filing ↗
- Alight, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Alight, Inc.'s own proxy. As printed: 10,645,531. View filing ↗
- TriNet Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in TriNet Group, Inc.'s own proxy. As printed: 10,552,055. View filing ↗
- Asgn Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Asgn Incorporated's own proxy. As printed: 10,475,672. View filing ↗
- Encompass Health, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Encompass Health's own proxy. As printed: 10,297,258. View filing ↗
- Option Care Health, Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health's own proxy. As printed: 9,266,330. View filing ↗
- Robert Half International Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Robert Half International Inc.'s own proxy. As printed: 6,073,178. View filing ↗
- Kelly Services, Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Kelly Services's own proxy. As printed: 5,207,696. View filing ↗
- Cross Country Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-30. CEO total compensation as printed in Cross Country Healthcare, Inc.'s own proxy. As printed: 2,355,403. View filing ↗
- Section 10a, Premier, Inc. reciprocity. DEF 14A. Premier, Inc. names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, R1 RCM, Inc. reciprocity. DEF 14A. R1 RCM, Inc.'s most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, ASGN Incorporated reciprocity. DEF 14A. ASGN Incorporated's most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Korn Ferry reciprocity. DEF 14A. Korn Ferry's most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Insperity, Inc. reciprocity. DEF 14A. Insperity, Inc.'s most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Alight, Inc. reciprocity. DEF 14A. Alight, Inc.'s most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Cross Country Healthcare, Inc. reciprocity. DEF 14A. Cross Country Healthcare, Inc. names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Evolent Health, Inc. reciprocity. DEF 14A. Evolent Health, Inc. names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Robert Half International Inc. reciprocity. DEF 14A. Robert Half International Inc.'s most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Encompass Health reciprocity. DEF 14A. Encompass Health names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Option Care Health reciprocity. DEF 14A. Option Care Health names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, TriNet Group, Inc. reciprocity. DEF 14A. TriNet Group, Inc.'s most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Kelly Services reciprocity. DEF 14A. Kelly Services's most recent proxy was read; its disclosed peer group does not include AMN Healthcare Services. View filing ↗
- Section 10a, Teledoc Health reciprocity. DEF 14A. Teledoc Health names AMN Healthcare Services in its own disclosed peer group (read from its most recent proxy). View filing ↗